Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study
Walsh, Elaine M., Gucalp, Ayca, Patil, Sujata, Edelweiss, Marcia, Ross, Dara S., Razavi, Pedram, Modi, Shanu, Iyengar, Neil M., Sanford, Rachel, Troso-Sandoval, Tiffany, Gorsky, Mila, Bromberg, Jacqueline, Drullinsky, Pamela, Lake, Diana, Wong, Serena, DeFusco, Patricia Ann, Lamparella, Nicholas, Gupta, Ranja, Tabassum, Tasmila, Boyle, Leigh Ann, Arumov, Artavazd, Traina, Tiffany A.
Published in Breast cancer research and treatment (01.10.2022)
Published in Breast cancer research and treatment (01.10.2022)
Get full text
Journal Article
Abstract P1-14-03: Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
Walsh, Elaine M, Gucalp, Ayca, Patil, Sujata, Edelweiss, Marcia, Ross, Dara S, Razavi, Pedram, Modi, Shanu, Iyengar, Neil M, Sanford, Rachel, Troso-Sandoval, Tiffany, Gorsky, Mila, Bromberg, Jackie, Drullinsky, Pamela, Lake, Diana, Wong, Serena, DeFusco, Patricia, Lamparella, Nicholas, Gupta, Ranja, Tabassum, Tasmila, Boyle, Leigh Ann, Arumov, Artavazd, Traina, Tiffany A
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article